Networks critical to disrupting illegal medicines trade in Asia
This article was originally published in SRA
A new report on transnational organized crime in East Asia and the Pacific from the United Nations Office on Drugs and Crime (UNODC) makes sobering reading1. Not only for its overview of billions of dollars in illicit trade in narcotics, counterfeit goods, wildlife and people, but also because it tries to quantify Asia's fake medicines problem.
You may also be interested in...
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This selection of recent insights from our experienced on-the-ground team will help.